Lorlatinib In Pretreated Alk/Ros1-Positive Non-Small Cell Lung Cancer (Nsclc): Results From The German Early Access ProgramN. Frost,P. Christopoulos, D. Kauffmann-Guerrero,J. A. Stratmann,R. Riedel,M. Schaefer,J. Alt, S. Guetz, J. Brinkmann,F. GriesingerAnnals of Oncology（2020）引用 1|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
